TGFB1 and breast carcinoma: An interesting study demonstrated that TGF-β levels were significantly decreased incocultures of breast cancer and bone marrow, unlike insulin-like growth factor [16].Taken together, these extensive findings indicate that the TGF-β signaling pathway provides a valuable targetfor anticancer efforts.